Schizophrenia is one of the most complex and disabling diseases to affect mankind. Relatively little is known about its nature and its origins, and available treatments are inadequate for most patients. As a result, there are inevitable controversies about what causes it, how to diagnose it, and how best to treat it. However, in the past decade, there has been an explosion of new research, with dramatic discoveries involving genetic etiology and epidemiological risk factors. There has also been a catalog of new drugs coming to market, and controversy about the relative advantages and disadvantages of newer compared with older therapies. In addition, developing technologies in genomics, molecular biology and neuroimaging provide streams of new information.
This book represents a definitive, essential, and up-to-date reference text on schizophrenia. It extensively and critically digests and clarifies recent advances and places them within a clinical context. The Editors (one American and one British), highly respected clinical psychiatrists and researchers and acknowledged experts on schizophrenia, have again assembled an outstanding group of contributors from the USA, UK, Europe and Australia, It will be of value to practising psychiatrists and to trainees, as well as to clinical and neuroscience researchers interested in keeping up with this field or coming into it.
The book consists of four sections: descriptive aspects, biological aspects, physical treatments, and psychological and social aspects. It reviews the theoretical controversies over symptomatology, classification and aetiology (particularly pertinent as DSM-V is being developed), the relationship of schizophrenia to the other psychoses, the significance of positive and negative symptoms and pre-morbid personality. It describes a variety of approaches to integrating the vast research data about schizophrenia, including neurodevelopmental, genetic, pharmacological, brain imaging and psychological findings. The biological treatment section reviews the comparative efficacy of various drugs, the management of drug-resistant patients and both neurological and metabolic complications. The final section looks at psychological therapies, social outcomes, and the economics of schizophrenia.
Highly Commended in the Psychiatry section of the 2012 BMA Book Awards.
"synopsis" may belong to another edition of this title.
Daniel R. Weinberger, Director: Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institute of Health, Bethesda, USA
Paul J. Harrison, University Department of Psychiatry, Warneford Hospital, Oxford, UK
"I thoroughly recommend this book as a well-integrated collection of thoughtful and up-to-date expositions on every aspect of schizophrenia, by some of the best scientists in the field. " (Psychological Medicine, 2012)
“It will be of valuable to practising psychiatrists and to trainees, as well as to the clinical and neuroscience researchers interested in keeping up with this field or coming into it.” (Buchtipps, September 2012)
"The contributing authors and editors constitute an international list of '"who's who" in contemporary schizophrenia research. Overall this book represents a highly systematic, comprehensive, scholarly, and critical appraisal of a core component of modern psychiatry and a major publice health challenge. It ably summarizes and evalutates efforts to better understand the nature, diagnosis, biology, psychology, sociology and clinical treatment of the group of largely "nonaffective" psychotic disorders currently considered within the nosological domain of schizophrenia. As such, it is an essential volume for students, researchers, clinicians, and administrators interested in improved understanding and care of persons diagnosed with psychotic disorders." (Journal of Clinical Psychiatry, 2012)
"About this title" may belong to another edition of this title.
Shipping:
FREE
Within U.S.A.
Shipping:
US$ 2.64
Within U.S.A.
Seller: Boards & Wraps, Baltimore, MD, U.S.A.
Hardcover. Condition: Very Good. Third Edition. Light rubbing and toning. Previous owner's dedication sticker to the ffep. Interior pages clean and unmarked. Photos upon request. International shipping billed at cost.; 4to 11" - 13" tall; 736 pages. Seller Inventory # 89957
Quantity: 1 available
Seller: Salish Sea Books, Bellingham, WA, U.S.A.
Condition: Good. 3. Good; Hardcover; 3rd Edition; Covers are still glossy with a few light handling-marks; Unblemished textblock edges; Scattered highlighting to about 50 pages, otherwise the endpapers and all text pages are clean and unmarked; The binding is excellent with a straight spine; This book will be shipped in a sturdy cardboard box with foam padding; Large Format (Quatro, 10.75" - 11.75" tall); 4.4 lbs; Black and blue covers with title in white and blue lettering; 2011, Wiley-Blackwell Publishing; 736 pages; "Schizophrenia," by Daniel R. Weinberger & Paul Harrison. Seller Inventory # SKU-1405AB04808124
Quantity: 1 available
Seller: p015, Rotterdam, Netherlands
Hardcover. Condition: Fair. Titel: Schizophrenia. Editie: 3rd Edition. Jaar van uitgave: 2011. Taal: Engels. Strak boek met sporen kaft. Schutblad vol geschreven verder schoon. Binnenwerk zeer goed. Enkele gebruik-/opslagsporen. Seller Inventory # 131123
Quantity: 1 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 5650923-n
Quantity: 2 available
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # GB-9781405176972
Quantity: 2 available
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: New. Seller Inventory # 5650923-n
Quantity: 2 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition. Seller Inventory # 5650923
Quantity: 2 available
Seller: Grand Eagle Retail, Wilmington, DE, U.S.A.
Hardcover. Condition: new. Hardcover. Schizophrenia is one of the most complex and disabling diseases to affect mankind. Relatively little is known about its nature and its origins, and available treatments are inadequate for most patients. As a result, there are inevitable controversies about what causes it, how to diagnose it, and how best to treat it. However, in the past decade, there has been an explosion of new research, with dramatic discoveries involving genetic etiology and epidemiological risk factors. There has also been a catalog of new drugs coming to market, and controversy about the relative advantages and disadvantages of newer compared with older therapies. In addition, developing technologies in genomics, molecular biology and neuroimaging provide streams of new information. This book represents a definitive, essential, and up-to-date reference text on schizophrenia. It extensively and critically digests and clarifies recent advances and places them within a clinical context. The Editors (one American and one British), highly respected clinical psychiatrists and researchers and acknowledged experts on schizophrenia, have again assembled an outstanding group of contributors from the USA, UK, Europe and Australia, It will be of value to practising psychiatrists and to trainees, as well as to clinical and neuroscience researchers interested in keeping up with this field or coming into it. The book consists of four sections: descriptive aspects, biological aspects, physical treatments, and psychological and social aspects. It reviews the theoretical controversies over symptomatology, classification and aetiology (particularly pertinent as DSM-V is being developed), the relationship of schizophrenia to the other psychoses, the significance of positive and negative symptoms and pre-morbid personality. It describes a variety of approaches to integrating the vast research data about schizophrenia, including neurodevelopmental, genetic, pharmacological, brain imaging and psychological findings. The biological treatment section reviews the comparative efficacy of various drugs, the management of drug-resistant patients and both neurological and metabolic complications. The final section looks at psychological therapies, social outcomes, and the economics of schizophrenia. Highly Commended in the Psychiatry section of the 2012 BMA Book Awards. Schizophrenia is one of the most complex and disabling diseases to affect mankind. Relatively little is known about its nature and its origins, and available treatments are inadequate for most patients. As a result, there are inevitable controversies about what causes it, how to diagnose it, and how best to treat it. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Seller Inventory # 9781405176972
Quantity: 1 available
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In. Seller Inventory # ria9781405176972_new
Quantity: 2 available
Seller: GreatBookPricesUK, Castle Donington, DERBY, United Kingdom
Condition: As New. Unread book in perfect condition. Seller Inventory # 5650923
Quantity: 2 available